Clinical Trials List
Protocol NumberV710-003
2008-02-01 - 2010-12-31
Phase II
Terminated3
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- NAI-HSIN CHI Division of Cardiovascular Surgery
- Jiun-Ling Wang Division of Infectious Disease
- YIH-SHARNG CHEN Division of Cardiovascular Surgery
- 王峻令 Division of Infectious Disease
- - - Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳典育 Division of Cardiovascular Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 蔡宜廷 Division of Cardiovascular Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
8044 participants
